VR for Chronic Pain: Beyond Mental Health

Chronic Pain: Why It's a Different Terrain Than Classic Psychotherapy

Chronic pain (defined as pain persisting beyond three months) affects a notable share of the adult population and is one of the leading causes of work disability in Europe. Its treatment is multimodal out of clinical necessity, not theoretical preference: analgesic medication, physical therapy, rehabilitation, psychological intervention, lifestyle management, and, in some cases, interventional techniques.

The psychological component isn't secondary. The accumulated evidence (cognitive-behavioral therapy for chronic pain, mindfulness-based programs such as Jon Kabat-Zinn's MBSR, acceptance and commitment therapy) shows effects on functional interference, mood associated with pain, and medication use, even when reported pain intensity doesn't drop dramatically. Psychological intervention works on the patient's relationship with their pain, not on the nociceptive stimulus itself.

Virtual reality enters this equation as a tool whose efficacy relies on mechanisms partly distinct from those of classic psychotherapy, and that is exactly what makes it interesting for psychologists who treat chronic pain in practice.

The Regulatory Milestone: RelieVRx and FDA Clearance

In November 2021, the U.S. FDA cleared RelieVRx (AppliedVR) as a prescription therapeutic device for treating chronic low back pain in adults. It's an eight-week at-home protocol, with daily sessions of roughly ten minutes, in which the patient practices guided diaphragmatic breathing, exposure to relaxing environments, mindful-movement exercises, and psychoeducational modules about the pain experience.

The milestone isn't only regulatory. It's the first time a health-authority-cleared VR program has entered the catalog of prescribable interventions for a highly prevalent chronic condition. The right clinical reading is a cautious one: the FDA clearance rests on trials with an active control group showing significant effects on pain interference and quality of life, not on eradicating pain. It is complementary efficacy, not a definitive treatment. about

In Europe, the regulatory picture is different. RelieVRx does not carry a CE mark as a medical device and is not available for prescription within the Spanish public health system. VRET, for its part, is a tool that supports psychotherapy, not a CE-marked medical device. This difference matters for the clinician deciding whether to incorporate VR into chronic-pain protocols.

Mechanisms: Why VR Works for Pain

Three partially overlapping mechanisms explain the effect of VR on the pain experience.

First, attentional distraction. The gate control theory proposed by Melzack and Wall, revisited and refined over decades, holds that attention directed toward non-nociceptive stimuli modulates the arrival of the painful stimulus at higher cortical levels. VR occupies attentional bandwidth with visual, auditory, and sometimes haptic stimuli, leaving fewer resources available to process pain. This explains the effect seen in acute pain (brief procedures, wound care, initial physical therapy).

Second, cortical attentional modulation. Neuroimaging studies with SnowWorld (Hoffman and colleagues) in patients with acute burns during wound care showed reduced activity in brain regions associated with the pain experience while patients were immersed in the virtual environment. The effect isn't just subjective distraction; it's documented neurophysiological modulation.

Third, cognitive restructuring and movement exposure. In chronic pain, part of the presentation is maintained by kinesiophobia (fear of movement in anticipation of pain) and catastrophizing. VR protocols combine gradual exposure to movement in safe environments with psychoeducation about the nature of chronic pain. This component is closer to classic psychotherapeutic work, and it's where the psychologist adds the most value.

Which Types of Pain Respond Best

The available literature allows for a reasonably clear picture of where VR has the strongest evidence and where the effect is more limited.

Acute procedural pain (burn wound care, initial physical therapy, brief procedures): solid evidence from Hoffman's work with SnowWorld and later replications. Immersive attentional distraction during brief procedures shows consistent effects on reported pain and procedure-related anxiety.

Chronic low back pain: well-established evidence thanks to the AppliedVR program and independent academic studies. Effects are documented for functional interference, mood associated with pain, and medication use, more so than for pure pain intensity.

Chronic musculoskeletal pain (fibromyalgia, neck pain, joint pain): more heterogeneous evidence, with promising studies but less consistency. Garcia-Palacios and colleagues at Universitat Jaume I (Castellón, Spain) have worked extensively in this area, and the general reading is that VR adds value when integrated into a multimodal program, not as a stand-alone intervention.

Neuropathic pain: limited and heterogeneous evidence. The mechanisms are partly distinct from those of nociceptive pain, with less response to distraction and greater relevance of specialized pharmacological treatment.

Headache and migraine: preliminary evidence. Immersion can be counterproductive during acute episodes in patients sensitive to visual stimuli; the indication would be during the between-episode phase, for regulation-skills training.

Where the Clinical Psychologist Fits In

The clinical psychologist who treats chronic pain in practice has a well-defined territory of their own: psychoeducation about the nature of chronic pain, cognitive work on catastrophizing, gradual exposure to movement, mindfulness applied to pain, and acceptance and commitment therapy to reorient the patient's life around values rather than around pain avoidance.

VR integrates as a tool within this work, not as a substitute. Some practical applications: intensive in-session training of regulation skills (breathing, mindfulness, body awareness in immersive environments); gradual exposure to movement perceived as threatening in patients with marked kinesiophobia; immersive relaxation environments as an anchor for skills the patient will later practice without the headset; group work (where applicable) built around immersive sessions as its backbone.

The current VRET scenarios that fit best are the immersive mindfulness module (forest, nature) and, for patients with kinesiophobia, progressive exposure to environments where movement is built into the exercise. We don't currently offer a RelieVRx-type chronic-pain-specific module; the clinical and regulatory investment such a program would require goes beyond the scope of a psychotherapy-support product today.

Cautions and Limits

Chronic pain is a domain with clinical peculiarities that deserve respect.

First, VR is not a stand-alone treatment for pain. It's part of multimodal programs under medical coordination and, where applicable, followed by specialized pain units.

Second, in patients with marked central sensitization (amplified pain, sensory hypersensitivity), immersion can be excessive at first. Low-stimulation scenarios, brief sessions, and gradual adjustment are advisable.

Third, cybersickness is more common in patients with chronic pain than in the general population, possibly due to interactions with analgesic medication or sensory hypervigilance. Introduction should be careful, with short initial sessions and monitoring for nausea or dizziness afterward.

And fourth, the therapeutic promise should be proportionate. Over the course of their healthcare journey, the patient with chronic pain has encountered plenty of promises that went unfulfilled. Integrating VR into practice should be presented as a useful tool within a broader course of treatment, not as a solution that will change everything. The VRET clinical team never uses language that promises pain elimination or assured outcomes.

This article is for informational purposes for psychology professionals. It is not clinical advice for any individual case and does not replace the judgment of the licensed psychologist in charge. VRET is professional clinical-support software, not a CE-marked medical device.